New paper
|
7
|
Resverlogix Corp.
|
Mar 19, 2023 08:04AM
|
Re: National Kidney Foundation -Abstract: BOM
|
7
|
Resverlogix Corp.
|
Mar 30, 2020 07:02PM
|
Re: BOM 2 Trial
|
7
|
Resverlogix Corp.
|
Jun 10, 2020 05:37PM
|
Re: Looking for clues:
|
7
|
Resverlogix Corp.
|
Nov 30, 2019 03:45PM
|
Congestive Heart Failure
|
7
|
Resverlogix Corp.
|
Nov 18, 2019 04:30PM
|
HIV
|
7
|
Resverlogix Corp.
|
Nov 18, 2019 04:51PM
|
Re: Long covid trials
|
7
|
Resverlogix Corp.
|
Aug 03, 2023 09:01PM
|
Trial design issues
|
7
|
Resverlogix Corp.
|
May 09, 2021 06:06PM
|
Re: Please help
|
7
|
Resverlogix Corp.
|
Mar 31, 2021 07:40PM
|
Re: Interim Analysis
|
7
|
Resverlogix Corp.
|
Oct 16, 2020 05:21PM
|
Re: NFK meeting
|
7
|
Resverlogix Corp.
|
Feb 21, 2020 07:44AM
|
Re: Wow! Quite the read!
|
7
|
Resverlogix Corp.
|
May 29, 2021 06:28PM
|
Re: Future Trials
|
7
|
Resverlogix Corp.
|
Feb 14, 2020 02:40PM
|
Re: Presentation is gone
|
7
|
Resverlogix Corp.
|
May 14, 2021 05:29PM
|
Re: Question re ALP
|
7
|
Resverlogix Corp.
|
Dec 15, 2019 07:10PM
|
Re: New RVX Tweet
|
7
|
Resverlogix Corp.
|
Aug 02, 2020 03:42PM
|
Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients
|
7
|
Resverlogix Corp.
|
Jun 13, 2023 07:24PM
|
Re: Resverlogix to Present at Upcoming Conferences
|
7
|
Resverlogix Corp.
|
Oct 13, 2021 02:39PM
|
Re: For Scientists - Nature article/study on epigenetic changes after kidney injury
|
7
|
Resverlogix Corp.
|
Jul 07, 2020 07:40PM
|
RVX by inhaler?
|
7
|
Resverlogix Corp.
|
Aug 04, 2021 05:51PM
|